Saigen Parenterals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.42 M
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 3.25%
- Profit Growth -1.68%
- Ebitda -1.68%
- Net Worth -12.77%
- Total Assets -0.24%
About Saigen Parenterals
Saigen Parenterals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 July 2008 and has a history of 16 years and six months. Its registered office is in Kolkata, West Bengal, India.
The Corporate was formerly known as Khatwang Traders Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.42 M, as per Ministry of Corporate Affairs (MCA) records.
Brij Golyan and Leela Golyan serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909WB2008PTC127798
-
Company No.
127798
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jul 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Saigen Parenterals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Brij Golyan
|
Director | 01-Jan-2011 | Current |
|
Leela Golyan
|
Director | 01-Jan-2011 | Current |
Financial Performance of Saigen Parenterals.
Saigen Parenterals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.25% increase. The company also saw a slight decrease in profitability, with a 1.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saigen Parenterals?
In 2022, Saigen Parenterals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shree Shyam Plantations Private LimitedBrij Golyan and Leela Golyan are mutual person
-
Teesta Plantations Private Limited
Brij Golyan and Leela Golyan are mutual person
-
Brijstar Green Energy Private Limited
Brij Golyan and Leela Golyan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Saigen Parenterals?
Unlock and access historical data on people associated with Saigen Parenterals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saigen Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saigen Parenterals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
